Freiburg Coronary Diagnostics and Therapy Registry

Freiburg Coronary Diagnostics and Therapy Registry - FCDT Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024590

Enrollment

500

Registered

2021-04-19

Start date

2021-04-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I21 I25

Interventions

Group 1: 1. index hospitalization: periinterventional characteristics 2. long-term follow-up (after 6, 12 and 24 months)

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Adult patients - Informed Consent - Received coronary angiohraphy or intervention

Exclusion criteria

Exclusion criteria: - Refusal by patient

Design outcomes

Primary

Measure	Time frame
Successful coronary intervention (PCI) (%) - Procedural characteristics o Pre- and post-procedure time (min) o Procedure duration ("incision-suture time") (min) - Diagnostic (min) and intervention (min) o Amount of contrast medium (ml) o Fluoroscopy time (min) - Diagnostics (min) and intervention (min) o Radiation dose for examiner (dose-area product (cGycm²)) o Radiation dose for patient (Dose-area product (cGycm²) o Recording of periprocedural complications (%) - Myocardial infarction1 (%) - MACE (major adverse cardiovascular events)2 (%) - Stent thrombosis (%) - Dissection (%) - Target vessel revascularization (%) o Evolution of intervention rate (min)	—

Measure

Time frame

Successful coronary intervention (PCI) (%) - Procedural characteristics o Pre- and post-procedure time (min) o Procedure duration ("incision-suture time") (min) - Diagnostic (min) and intervention (min) o Amount of contrast medium (ml) o Fluoroscopy time (min) - Diagnostics (min) and intervention (min) o Radiation dose for examiner (dose-area product (cGycm²)) o Radiation dose for patient (Dose-area product (cGycm²) o Recording of periprocedural complications (%) - Myocardial infarction1 (%) - MACE (major adverse cardiovascular events)2 (%) - Stent thrombosis (%) - Dissection (%) - Target vessel revascularization (%) o Evolution of intervention rate (min)

—

Secondary

Measure	Time frame
Mortality - Long-term assessment of intervention success o Death (%), cardiovascular death (%), and time to death (m) o Rehospitalization rate (%) o Need for reintervention (%) o Target vessel failure3 (%) and time to failure (m) Health-related quality of life survey - NYHA score - Canadian Cardiovascular Society (CCS) Angina Grade - EuroQoL 5D (EQ-5D-5L) - Seattle angina questionnaire - 7 short form (SAQ-7)	—

Measure

Time frame

Mortality - Long-term assessment of intervention success o Death (%), cardiovascular death (%), and time to death (m) o Rehospitalization rate (%) o Need for reintervention (%) o Target vessel failure3 (%) and time to failure (m) Health-related quality of life survey - NYHA score - Canadian Cardiovascular Society (CCS) Angina Grade - EuroQoL 5D (EQ-5D-5L) - Seattle angina questionnaire - 7 short form (SAQ-7)

—

Countries

Germany

Contacts

Public ContactJonathan Rilinger

Klinik für Kardiologie und Angiologie I Universitätsherzzentrum Freiburg – Bad Krozingen

jonathan.rilinger@uniklinik-freiburg.de+49 761-270-34010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026